The Limited Times

Now you can see non-English news...

A blow to nature: The legendary investor is tired of waiting for recovery - Walla! Of money

2022-02-15T09:19:15.627Z


The investment guru and Berkshire Hathaway owners, sold the Teva shares that were owned by the company. The loss is estimated at more than a billion shekels. Teva shares were acquired by Buffett about four years ago


A blow to nature: The legendary investor is tired of waiting for recovery

Warren Buffett, the investment guru and Berkshire Hathaway owner, sold the shares in Teva that were owned by the company.

The loss is estimated at more than a billion shekels.

Teva shares were acquired by Buffett about four years ago, following the appointment of Karl Schultz as the company's CEO

Walla!

Of money

15/02/2022

Tuesday, 15 February, 2022, 10:46 Updated: 11:13

  • Share on Facebook

  • Share on WhatsApp

  • Share on Twitter

  • Share on Email

  • Share on general

  • Comments

    Comments

Has the stock formerly known as the "People's Share" completely lost its charm in the eyes of investors?

It may be too early to know, but there is no doubt that Teva, in the past a source of Israeli pride in the international business arena, has suffered a prestigious blow, which may also be reflected in price declines.



Reports from the fourth quarter of 2021, by Berkshire Hathaway Investment Company, whose name is most associated with it, Warren Buffett, show that the company has sold all its holdings in the wild.



Teva shares respond to news of price declines, which come after a few more successful days per share - thus continuing the decline in the share price that has been recorded in recent months.

More on Walla!

Someone has discovered the secret: how do you look perfect without leaving home?

In collaboration with Fortuna

nature.

Will the sale of the legendary investor's holdings project on the market (Photo: Sivan Farage)

They lost more than a billion shekels

As stated, the company did not report the sale of Teva shares, but the report it submitted to the US Stock Exchange shows that it divested its holdings in the pharmaceutical company Mabelach in the fourth quarter of 2021. A comparative examination of the share price at the time of purchase reflects a loss of over To $ 350 million, as a result of the failed round at Teva.



It should be noted that Buffett's company decided to acquire Teva shares about four years ago, after Carr Schultz established himself in the CEO's chair and presented a recovery plan for the company.

Following the investment of someone who is considered one of the smartest investors on Wall Street, enthusiasm caught up with other investors as well and Teva's stock soared.



Despite this, as the years passed and after Teva did not present an impressive business performance, the investment company decided to give up the shares, even if with a significant financial loss.

Warren Buffett (right) and his deputy at the investment company, Charlie Manger: What they lost in nature, they gained with interest in Activision (Photo: AP)

And Buffett also had bigger currency successes

It should be noted that Berkshire Hathaway has experienced much greater success: the company's reports reveal that it has acquired shares of Activision, which was sold to Microsoft for a whopping $ 70 billion, before the gaming company was sold.

The shares were purchased for close to $ 1 billion, so both Warren Buffett and Bershire Hathaway will likely be able to recover from the less successful round in nature.

  • Of money

Tags

  • nature

  • Warren Buffett

  • Wall Street

Source: walla

All business articles on 2022-02-15

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.